Efficacy, Safety, and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: A Randomized, Double-Blind Phase 3 Study, MEASURE 3

Arthritis Research & Therapy

doi 10.1186/s13075-017-1490-y

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search